3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
12
Breast Neoplasms
9
Polycystic Ovary Syndrome
8
Obesity
7
Colorectal Neoplasms
7
Weight Loss
5
Colonic Neoplasms
5
Neoplasms
4
Endometrial Neoplasms
4
Prostatic Neoplasms
3
Multiple Endocrine Neoplasia Type 1
3
Recurrence
2
Pancreatic Neoplasms
2
Overweight
2
Ovarian Neoplasms
2
Malnutrition
2
Lymphoma, Follicular
2
Lymphoma
2
Carcinoma, Intraductal, Noninfiltrating
2
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polyps
1
Patient Compliance
1
Interventions
relacorilant
5
Resistance Training
3
Pioglitazone
2
Nutritional Status
2
Metformin
2
saxagliptin
1
pembrolizumab
1
mazdutide
1
dapagliflozin
1
Sitagliptin Phosphate
1
Resistant Starch
1
Plant Proteins
1
Nutrition Assessment
1
Methods
1
Insulin Lispro
1
Insulin Glargine
1
Exercise Movement Techniques
1
Exercise
1
Ethanol
1
Endodontics
1
Educational Status
1
Early Intervention, Educational
1
Diet
1
Continuous Glucose Monitoring
1
Circuit-Based Exercise
1
Cholecalciferol
1
Blood Specimen Collection
1
Ascorbic Acid
1
ASP3662
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Diabetes Mellitus, Type 2
×
Diet
×
Clear all
NCT03206827
2021-09-27
ScenoProt
University of Helsinki
Phase NA
Completed
147 enrolled